Alvesco Additionally Approved for Adolescents in Europe; Approval for All Severities of Persistent Asthma; Strengthening of Product Profile.

Business Wire › February 17, 2006

Linked as:

Extract

Alvesco Additionally Approved for Adolescents in Europe; Approval for All Severities of Persistent Asthma; Strengthening of Product Profile.

BAD HOMBURG & KONSTANZ, Germany -- ALTANA AG (NYSE:AAA) (FWB:ALT) (GER:ALT) has announced today that the indication of Alvesco(R) (ciclesonide), a novel inhaled corticosteroid (ICS), has been ext...

See the full content of this document